<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Article Tag Suite 1.1//EN"
  "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink"
         xmlns:mml="http://www.w3.org/1998/Math/MathML"
         article-type="research-article"
         xml:lang="en">
  <front>
    <journal-meta>
      <journal-title-group>
        <journal-title>American Journal of PharmTech Research</journal-title>
        <abbrev-journal-title abbrev-type="publisher">AJPTR</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="epub">2249-3387</issn>
      <publisher>
        <publisher-name>undefined</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">AJPTR72019</article-id>
      <title-group>
        <article-title>Synthesis, Characterization of Some Novel Schiff bases Derived from Imidazo [1, 2-a] pyridines for Anti-inflammatory and Antibacterial Activities</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Sikender</surname>
            <given-names>Mood</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Begum</surname>
            <given-names>Ameena</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Unyala</surname>
            <given-names>Rishika</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hepsibha</surname>
            <given-names>Chirra</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Reddy</surname>
            <given-names>B.Madhava</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Babu</surname>
            <given-names>V.Harinadha</given-names>
          </name>
        </contrib>
      </contrib-group>
      <pub-date pub-type="epub" iso-8601-date="2017-04-01">
        <month>04</month>
        <day>01</day>
        <year>2017</year>
      </pub-date>
      <volume>7</volume>
      <issue>2</issue>
      <abstract>
        <p>Imidazo [1, 2-a] pyridine based Schiff bases have been synthesized by condensing different 3-aryl-5-methyl isoxazole hydrazides with 2-aryl imidazo [1, 2-a] pyridine carbaldehydes by following hybridization approach. The structures of newly synthesized Schiff bases have been characterized by spectral data and elemental analysis. In In vivo anti-inflammatory screening, compounds 4b &amp; 4f showed significant activity and the results are comparable with the standard drug, diclofenac. None of the compounds exhibited significant activity in anti-bacterial study. The work might result in the emergence of new series of compounds with potent anti-inflammatory activity.</p>
      </abstract>
      <kwd-group kwd-group-type="author">
        <kwd>Imidazo [1</kwd>
        <kwd>2-a] pyridines</kwd>
        <kwd>isoxazole hydrazides</kwd>
        <kwd>Schiff bases</kwd>
        <kwd>anti-bacterial activity</kwd>
        <kwd>anti-inflammatory activity</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <!-- Full article body not available in metadata-only JATS export. See PDF/HTML galley. -->
  </body>
  <back/>
</article>
